Researchers develop affordable, rapid blood test for brain cancer: Biochip that uses electrokinetic technology to detect biomarkers, or active Epidermal Growth Factor Receptors (EGFRs),which are overexpressed in certain cancers such as glioblastoma and found in extracellular vesicles.

Read Full Article

#BrainCancer #BiochipTechnology #EGFRs #Glioblastoma #BloodTest

New blood test could help spot children at risk of serious illnesses, study finds | Lipid analysis using existing machines could give warning of type 2 diabetes, liver and heart disease, researchers say

Read Full Article

#health #children #bloodtest #earlydetection #research

An experimental blood test detects early-stage pancreatic cancer more effectively than other available tests, identifying 71% of pancreatic cancer samples

Read Full Article

#pancreaticcancer #earlydetection #bloodtest #cancertesting #healthcareinnovation

Simple £5 blood test could help prevent thousands of heart attacks, study says. Checking levels of troponin in patients could enable doctors to predict their risk of cardiovascular events with much greater accuracy, according to a study funded by the British Heart Foundation.

Read Full Article

#HeartHealth #CardiovascularResearch #BloodTest #PreventHeartAttacks #BritishHeartFoundation

Researchers have developed a simple and “cost-effective” blood test capable of detecting Parkinson’s disease long before symptoms emerge, according to a study. The test uses the same PCR technology used during the pandemic to confirm Covid cases.

Read Full Article

#ParkinsonsDisease #BloodTest #HealthInnovation #MedicalResearch #EarlyDetection

Annual multi-cancer early detection blood tests could spot cancer early and help more people survive cancer. 🩸🎗️ The blood test looks for DNA fragments shed by tumors. Annual blood testing was associated with 49% fewer late-stage cancer diagnoses and 21% fewer deaths within five years.

Read Full Article

#CancerAwareness #EarlyDetection #BloodTest #HealthInnovation #Survivorship

Cancers can be detected in the bloodstream 3 years prior to diagnosis. Investigators were surprised they could detect cancer-derived mutations in the blood so much earlier. 3 years earlier provides time for intervention. The tumors are likely to be much less advanced and more likely to be curable. 🩺🧬🔬✨

Read Full Article

#EarlyDetection #CancerResearch #BloodTest #HealthInnovation #CurableCancer

A new blood test allows the identification of individuals at risk for developing multiple sclerosis (MS) 🩸🧠 with a high degree of certainty years before the onset of symptoms.

Read Full Article

#MultipleSclerosis #BloodTest #HealthInnovation #MSAwareness #MedicalBreakthrough

Dana-Farber Cancer Institute unveils groundbreaking blood test for multiple myeloma 🩸🔬✨

Read Full Article

#DanaFarber #CancerResearch #MultipleMyeloma #BloodTest #MedicalInnovation

A simple blood test 🧪 can help detect cancer 🩺 in patients with non-specific symptoms 🤒 such as fatigue 😓, pain 🤕 or weight loss ⚖️, thanks to a protein signature 🧬 that could be linked to a cancer diagnosis 🎗️

Read Full Article

#CancerDetection #BloodTest #ProteinSignature #EarlyDiagnosis #NonSpecificSymptoms

Researchers have developed a blood test that may detect early pancreatic cancer, one of the deadliest forms of cancer. The new test could improve survival rates from pancreatic cancer, which tends to be diagnosed at late stages when therapy is less likely to be effective

Read Full Article

#EarlyDetection #PancreaticCancer #BloodTest #CancerResearch #Survival

🔬 Blood tests detecting the protein p-tau217 show promise in predicting the age of Alzheimer's symptom onset up to 3-4 years in advance for those without cognitive impairment.

🧠 The study involved over 600 individuals aged 62-78, using blood tests to estimate when symptoms might develop, with a finding that older individuals with a positive test may experience earlier symptom onset.

⚠️ Experts caution that while encouraging, these tests are not yet ready for widespread clinical use due to accuracy concerns and the complexity of Alzheimer's, recommending against their use in asymptomatic individuals.

#Alzheimers #BloodTest #MedicalBreakthrough

Researchers at Charles University's Second Faculty of Medicine found specific oxidative waste products in red blood cells that are uniquely elevated in Alzheimer's. This could allow for a simple, accurate blood test to detect Alzheimer's early and distinguish it from other types of dementia

Read Full Article

#AlzheimersDetection #BloodTest #DementiaResearch

A Blood Test May Detect the Conditions That Lead to Lung Cancer Years Before It Appears

Read Full Article

#LungCancer #EarlyDetection #BloodTest

A blood test for dementia may tell you if you have more than one type | The test can help diagnose four neurodegenerative diseases — Alzheimer's, Parkinson's, frontotemporal dementia and dementia with Lewy bodies — based on levels of 15 proteins in the blood.

Read Full Article

#DementiaDiagnostics #BloodTest #NeurodegenerativeDiseases

🔬 A new, highly sensitive blood test (ddPCR) detected pancreatic cancer traces missed by standard tests (NGS) in 106 Northwestern Medicine patients, potentially identifying those at higher risk of recurrence.

📈 At diagnosis, ddPCR found tumor KRAS DNA in 65% of patients, compared to 17% for NGS. After surgery, ddPCR detected it in 56% of patients, while NGS found it in only 9%.

📊 Patients whose cancer was detected by ddPCR but missed by NGS survived a median of 27 months, significantly less than the 41 months for patients negative on both tests.

fármacos Targeted KRAS mutations are key to this test, aligning with emerging KRAS-targeting drugs nearing FDA review, which show substantial survival benefits.

#PancreaticCancer #BloodTest #KRAS

Blood-Based Test Can Predict Risk of Developing Symptoms of Alzheimer's Up to a Decade Early

Read Full Article

#AlzheimersPrevention #BloodTest #EarlyDetection

🔬 A new study, published in JAMA and presented at the Alzheimer’s Association International Conference, analyzed data from 2,684 cognitively unimpaired adults across North America, Japan, and Australia. It found that individuals with very high levels of the biomarker p-tau217 had a 38% absolute risk of developing cognitive impairment within five years, and a 78% risk over 10 years.

🧑‍⚕️ While federal clearance has been granted for p-tau217 blood tests, current medical advice for asymptomatic individuals remains unchanged: prioritize regular exercise, a healthy diet, sufficient sleep, and overall wellness. Experts suggest these tests could become valuable for identifying individuals who might benefit from future disease-modifying treatments for Alzheimer's.

📊 The research, led by Mass General Brigham Neuroscience Institute, highlights that p-tau217 levels predicted risk independently of other known factors like amyloid plaques and genetic predispositions. The study also noted that data for 10-year outcomes and beyond was less comprehensive.

#Alzheimers #BloodTest #Neuroscience

While 93% of adults would take a new Alzheimer’s blood test, those closest to the disease might avoid it. Charles University's Second Faculty of Medicine researchers found that having a close family history of Alzheimer's actually reduces a person's willingness to get tested by 69%.

Read Full Article

#AlzheimersAwareness #BloodTest #GeneticRisk

🔬 An experimental blood test, DENEB, showed promising results in a study of over 1,500 adults, detecting 81% of high-risk precancerous polyps (advanced adenomas) and about 92% of early to mid-stage colorectal cancers.

🔬 The DENEB test analyzes microRNAs in blood, including those within exosomes, to detect molecular changes associated with colorectal abnormalities, aiming to identify precancerous lesions before they become cancer.

🔬 Published this week in The Lancet Gastroenterology & Hepatology, these findings are significant as current blood tests are better at detecting established cancers than these earlier precancerous growths.

🔬 While encouraging, researchers caution that further large-scale studies in diverse screening populations are needed to confirm the test's clinical usefulness, as the validation study included a higher proportion of people with polyps and cancer than typically found in general screenings.

#ColorectalCancer #BloodTest #CancerScreening